loading
전일 마감가:
$1.83
열려 있는:
$1.8
하루 거래량:
702.87K
Relative Volume:
0.35
시가총액:
$375.15M
수익:
$12.87M
순이익/손실:
$-114.34M
주가수익비율:
-2.0125
EPS:
-0.8646
순현금흐름:
$-79.23M
1주 성능:
+1.45%
1개월 성능:
+6.40%
6개월 성능:
-18.84%
1년 성능:
-41.05%
1일 변동 폭
Value
$1.73
$1.87
1주일 범위
Value
$1.694
$1.87
52주 변동 폭
Value
$1.19
$4.32

Taysha Gene Therapies Inc Stock (TSHA) Company Profile

Name
명칭
Taysha Gene Therapies Inc
Name
전화
(214) 612-0000
Name
주소
3000 PEGASUS PARK DRIVE, DALLAS
Name
직원
73
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
TSHA's Discussions on Twitter

TSHA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TSHA
Taysha Gene Therapies Inc
1.75 375.15M 12.87M -114.34M -79.23M -0.8646
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
509.14 131.61B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
665.39 73.51B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.70 37.67B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
254.18 32.81B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
260.66 28.62B 3.81B -644.79M -669.77M -6.24

Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-06-27 개시 BMO Capital Markets Outperform
2024-04-09 개시 Piper Sandler Overweight
2023-02-01 다운그레이드 Jefferies Buy → Hold
2023-01-27 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-11-09 다운그레이드 Goldman Buy → Neutral
2022-03-09 개시 Robert W. Baird Outperform
2022-03-01 개시 Wells Fargo Overweight
2022-02-18 개시 SMBC Nikko Outperform
2021-12-16 개시 Guggenheim Buy
2021-07-16 개시 Needham Buy
2021-06-24 개시 Truist Buy
2021-06-15 개시 BTIG Research Buy
2021-06-09 개시 Wedbush Outperform
2021-06-08 개시 JMP Securities Mkt Outperform
2021-05-19 개시 Cantor Fitzgerald Overweight
2021-05-11 재개 Jefferies Buy
2021-02-24 개시 William Blair Outperform
2021-01-05 개시 Oppenheimer Outperform
2020-10-19 개시 Chardan Capital Markets Buy
2020-10-19 개시 Goldman Buy
2020-10-19 개시 Jefferies Buy
2020-10-19 개시 Morgan Stanley Overweight
모두보기

Taysha Gene Therapies Inc 주식(TSHA)의 최신 뉴스

pulisher
Mar 19, 2025

Is Taysha Gene Therapies (TSHA) the Best Short Squeeze Stock to Buy According to Analysts? - Yahoo Finance

Mar 19, 2025
pulisher
Mar 19, 2025

10 Best Short Squeeze Stocks To Buy According to Analysts - Insider Monkey

Mar 19, 2025
pulisher
Mar 14, 2025

Analysts Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.63 - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Taysha Gene Therapies’ SWOT analysis: stock’s potential in Rett syndrome treatment By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 12, 2025

Taysha Gene Therapies’ SWOT analysis: stock’s potential in Rett syndrome treatment - Investing.com Australia

Mar 12, 2025
pulisher
Mar 11, 2025

Taysha Gene Therapies (TSHA) to Release Earnings on Tuesday - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 07, 2025
pulisher
Mar 07, 2025

Taysha Gene Therapies announces inducement grant under Nasdaq listing rule - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Taysha's Latest Stock Option Grants: Key Details for Institutional Investors - StockTitan

Mar 07, 2025
pulisher
Mar 03, 2025

TSHA FY2025 EPS Forecast Raised by Cantor Fitzgerald - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Needham & Company LLC Reaffirms Buy Rating for Taysha Gene Therapies (NASDAQ:TSHA) - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Chardan Capital Reiterates Buy Rating for Taysha Gene Therapies (NASDAQ:TSHA) - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

Taysha Gene Therapies’ Positive Earnings Call Highlights - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Positive Outlook for Taysha Gene Therapies: Buy Rating Backed by FDA Progress and Strong Financial Position - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2024 Earnings Call Transcript - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Taysha Gene Therapies, Inc. (TSHA) Reports Q4 Loss, Tops Revenue Estimates - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Taysha Gene Therapies Reports 2024 Financial Results - TipRanks

Feb 27, 2025
pulisher
Feb 26, 2025

Positive Outlook on Taysha Gene Therapies: Promising Developments and Financial Stability - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Feb 26, 2025
pulisher
Feb 26, 2025

Taysha Gene Therapies reports FY24 EPS (36c) vs (96c) last year - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Taysha Gene Therapies Inc Reports Full Year 2024 EPS of -$0.36 a - GuruFocus.com

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings call transcript: Taysha Gene's Q4 2024 reports narrower loss, stock dips - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings call transcript: Taysha Gene’s Q4 2024 reports narrower loss, stock dips - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

Taysha Gene Therapies, Inc. SEC 10-K Report - TradingView

Feb 26, 2025
pulisher
Feb 26, 2025

Can Taysha's Gene Therapy for Rett Syndrome Deliver? Key Safety Milestone Reached as Cash Extends to 2026 - StockTitan

Feb 26, 2025
pulisher
Feb 25, 2025

Taysha Gene Therapies Inc (TSHA) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Feb 25, 2025
pulisher
Feb 21, 2025

Taysha Gene Therapies (TSHA) Projected to Post Earnings on Wednesday - Defense World

Feb 21, 2025
pulisher
Feb 20, 2025

Taysha Gene Therapies to Release Full-Year 2024 Financial - GlobeNewswire

Feb 20, 2025
pulisher
Feb 19, 2025

Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26 - The Manila Times

Feb 19, 2025
pulisher
Feb 19, 2025

Gene Therapy Pioneer Taysha Readies Crucial 2024 Financial DisclosureHere's When - StockTitan

Feb 19, 2025
pulisher
Feb 17, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $6.63 Average Price Target from Brokerages - Defense World

Feb 17, 2025
pulisher
Feb 15, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Sold by SG Americas Securities LLC - Defense World

Feb 15, 2025
pulisher
Feb 14, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 1.3%Time to Buy? - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Feb 14, 2025
pulisher
Feb 12, 2025

Critical Analysis: Creative Medical Technology (NASDAQ:CELZ) vs. Taysha Gene Therapies (NASDAQ:TSHA) - Defense World

Feb 12, 2025
pulisher
Feb 07, 2025

Taysha Gene Therapies Inc (TSHA) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Feb 07, 2025
pulisher
Feb 07, 2025

Taysha Gene Therapies Inc [TSHA] Records 50-Day SMA of $1.9835 - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Taysha's Strategic Move: 491K Stock Options Awarded to Secure Top Industry Talent - StockTitan

Feb 07, 2025
pulisher
Feb 06, 2025

Rett Syndrome Market Growth Projections 2024-2034: - openPR

Feb 06, 2025
pulisher
Feb 06, 2025

Prepare Yourself for Liftoff: Taysha Gene Therapies Inc (TSHA) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Octagon Capital Advisors LP Increases Stake in Taysha Gene Thera - GuruFocus.com

Feb 06, 2025
pulisher
Feb 05, 2025

Scienjoy Holding Leads Our 3 US Penny Stocks To Consider - Simply Wall St

Feb 05, 2025
pulisher
Feb 04, 2025

Taysha Gene Therapies Inc (TSHA)’s Market Momentum: Closing Strong at 1.53, Up 2.00 - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Technical analysis of Taysha Gene Therapies Inc (TSHA) stock chart patterns - US Post News

Feb 04, 2025
pulisher
Jan 27, 2025

Taysha Gene Therapies Is Showing Promise For Rett Syndrome - Seeking Alpha

Jan 27, 2025
pulisher
Jan 23, 2025

Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More - MedCity News

Jan 23, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Predicts TSHA FY2025 Earnings - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

Brokers Issue Forecasts for TSHA FY2025 Earnings - MarketBeat

Jan 22, 2025
pulisher
Jan 22, 2025

Illuminating Rett syndrome: Latest pharmacological advancements - The Pharma Letter

Jan 22, 2025
pulisher
Jan 20, 2025

Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) PT at $6.63 - MarketBeat

Jan 20, 2025

Taysha Gene Therapies Inc (TSHA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$79.70
price up icon 0.37%
$313.49
price down icon 1.68%
$33.42
price up icon 0.09%
$19.60
price down icon 1.10%
$98.86
price up icon 0.44%
biotechnology ONC
$264.15
price down icon 1.17%
자본화:     |  볼륨(24시간):